Thursday, 17 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14422
Articles
Company
Deals
Biomed Union Raises RMB 200M in Series B Round for Diagnostic Products
February 1, 2025
Company
Deals
Yaguo Technology Secures Series A+ Funding for Airway Management Devices
February 1, 2025
Company
Deals
Novatim Immune Therapeutics Raises RMB 500M in First Financing Round
February 1, 2025
Company
Deals
Pulnovo Medical Raises ‘Tens of Millions’ in New Financing Round
February 1, 2025
Company
Drug
Akeso Biopharma Completes Enrollment for AK112 Phase III Study
February 1, 2025
Company
Drug
Eccogene Gains FDA Approval for Phase I Study of ECC5004
February 1, 2025
Company
Drug
BeiGene’s Brukinsa Receives EU Marketing Approval for Marginal Zone Lymphoma
February 1, 2025
Company
Deals
Dartsbio Licenses Potential First-in-Class BsAb DS005 to Duality Biologics
March 3, 2025
Company
Deals
Fosun Pharma Terminates Equity Transfer Deal with OncoCare Medical
February 1, 2025
Company
Drug
Antengene’s CD73 Inhibitor ATG-037 Greenlit for Phase I Study by NMPA
February 1, 2025
Company
Medical Device
Sino Medical Sciences’ Non-Compliant Balloon Catheter Approved by NMPA
February 1, 2025
Company
Drug
Hengrui’s Pyrotinib Granted Breakthrough Therapy Designation by CDE
February 1, 2025
1
2
…
1,103
1,104
1,105
1,106
1,107
…
1,201
1,202
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?